CXCR5 and neoplasm: The treatment of mice with anti–PD-L1 combined with bacteria provided analogous control of tumor growth as the combination of the antibody with apyrase (Fig. 4C) as well as a similar increase in TNF-α+Granzyme B+ and CXCR5+ CD8 TILs (Fig. 4, D and E).